Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 225

    1.

    Food and Drug Administration approval of buprenorphine-naloxone for office treatment of addiction.

    Resnick RB.

    Ann Intern Med. 2003 Feb 18;138(4):360. No abstract available. PMID: 12585846 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Is buprenorphine-naloxone ready for prime time in the treatment of opioid addiction in managed care?

    Curtiss FR.

    J Manag Care Pharm. 2008 Mar;14(2):195-7. No abstract available. PMID: 18331121 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Drugs approved for opiate dependence.

    [No authors listed]

    FDA Consum. 2003 Jan-Feb;37(1):6. No abstract available. PMID: 12625293 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Office-based practice and opioid-use disorders.

    Clark HW.

    N Engl J Med. 2003 Sep 4;349(10):928-30. No abstract available. PMID: 12954740 [PubMed - indexed for MEDLINE]Related articles

    5.

    From the Food and Drug Administration.

    [No authors listed]

    JAMA. 2002 Dec 4;288(21):2678. No abstract available. PMID: 12460076 [PubMed - indexed for MEDLINE]Related articles

    6.

    Counseling buprenorphine patients: information and treatment approaches for counselors.

    McCann MJ.

    J Psychoactive Drugs. 2004 May;Suppl 2:139-46.PMID: 15279126 [PubMed - indexed for MEDLINE]Related articles

    7.

    Buprenorphine maintenance: a new treatment for opioid dependence.

    Collins GB, McAllister MS.

    Cleve Clin J Med. 2007 Jul;74(7):514-20. Review.PMID: 17682629 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Narrative review: buprenorphine for opioid-dependent patients in office practice.

    Sullivan LE, Fiellin DA.

    Ann Intern Med. 2008 May 6;148(9):662-70. Review.PMID: 18458279 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Recent advances in the treatment of opiate addiction.

    Fudala PJ, Woody GW.

    Curr Psychiatry Rep. 2004 Oct;6(5):339-46. Review.PMID: 15355756 [PubMed - indexed for MEDLINE]Related articles

    10.

    Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings.

    Mintzer IL, Eisenberg M, Terra M, MacVane C, Himmelstein DU, Woolhandler S.

    Ann Fam Med. 2007 Mar-Apr;5(2):146-50.PMID: 17389539 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Evolving use of buprenorphine in the treatment of addiction.

    Martin J.

    J Psychoactive Drugs. 2004 May;Suppl 2:129-37.PMID: 15279125 [PubMed - indexed for MEDLINE]Related articles

    12.

    Accessing opiate dependence treatment medications: buprenorphine products in an office-based setting.

    Leshner AI.

    Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S103-4. No abstract available. PMID: 12738354 [PubMed - indexed for MEDLINE]Related articles

    13.

    Opioid dependence treatment, including buprenorphine/naloxone.

    Raisch DW, Fye CL, Boardman KD, Sather MR.

    Ann Pharmacother. 2002 Feb;36(2):312-21. Review.PMID: 11847954 [PubMed - indexed for MEDLINE]Related articles

    14.

    Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.

    Amass L, Ling W, Freese TE, Reiber C, Annon JJ, Cohen AJ, McCarty D, Reid MS, Brown LS, Clark C, Ziedonis DM, Krejci J, Stine S, Winhusen T, Brigham G, Babcock D, Muir JA, Buchan BJ, Horton T.

    Am J Addict. 2004;13 Suppl 1:S42-66.PMID: 15204675 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Using buprenorphine for outpatient opioid detoxification.

    Manlandro JJ Jr.

    J Am Osteopath Assoc. 2007 Sep;107(9 Suppl 5):ES11-6. Review.PMID: 17908825 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Buprenorphine for office-based treatment of patients with opioid addiction.

    Manlandro JJ Jr.

    J Am Osteopath Assoc. 2005 Jun;105(6 Suppl 3):S8-13. Review.PMID: 16118361 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Office-based treatment of opioid-dependent patients.

    Ferner RE, Daniels AM.

    N Engl J Med. 2003 Jan 2;348(1):81-2; author reply 81-2. No abstract available. PMID: 12510051 [PubMed - indexed for MEDLINE]Related articles

    18.

    The implementation of buprenorphine/naloxone in college health practice.

    DeMaria PA, Patkar AA.

    J Am Coll Health. 2008 Jan-Feb;56(4):391-3. Review.PMID: 18316282 [PubMed - indexed for MEDLINE]Related articles

    19.

    Agency offers guidance on office-based drug treatment for opioid addiction.

    Mitka M.

    JAMA. 2003 Feb 12;289(6):690. No abstract available. PMID: 12585931 [PubMed - indexed for MEDLINE]Related articles

    20.

    Buprenorphine and addiction: challenges for the pharmacist.

    Boatwright DE.

    J Am Pharm Assoc (Wash). 2002 May-Jun;42(3):432-8.PMID: 12030630 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data